<DOC>
	<DOCNO>NCT01584609</DOCNO>
	<brief_summary>This prospective , randomize , single blind , concurrent control , multi-center study . Patients present symptom acute ischemic stroke evidence large vessel ( 2.5mm great diameter ) occlusion cerebral circulation assign either Penumbra System Separator 3D Penumbra System without Separator 3D . Each treat patient follow assessed 3 month randomization . Up 230 evaluable patient 50 center present acute ischemic stroke vessel accessible Penumbra Separator 3D System revascularization within 8 hour symptom onset . The hypothesis test safety effectiveness Penumbra System Separator 3D revascularization large vessel occlusion inferior Penumbra System alone .</brief_summary>
	<brief_title>A Randomized , Concurrent Controlled Trial Assess Safety Effectiveness Separator 3D Component Penumbra System Revascularization Large Vessel Occlusion Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>From 18 85 year age Present symptom consistent acute ischemic stroke revascularization within 8 hour symptom onset Refractory eligible IV rtPA therapy. , e.g. , present 0 3 hour symptom onset AND contraindicate IV rtPA , present 3 8 hour symptom onset , evidence persistent occlusion vascular image IV rtPA Evidence large vessel ( 2.5mm great diameter ) occlusion cerebral circulation NIH Stroke Scale ( NIHSS ) score 8 point Signed informed consent History stroke past 3 month . Females pregnant Preexisting neurological psychiatric disease could confound study result prestroke mRS score 1 high Known severe allergy contrast medium Uncontrolled hypertension ( define systolic blood pressure &gt; 185 mmHg diastolic blood pressure &gt; 110 mmHg ) CT evidence follow condition randomization : Significant mass effect midline shift Large infarct region &gt; 1/3 middle cerebral artery territory Evidence intracranial hemorrhage Angiographic evidence arterial stenosis proximal occlusion could prevent thrombus removal Angiographic evidence preexist arterial injury Rapidly improve neurological status prior enrollment Bilateral stroke Intracranial tumor Known history cerebral aneurysm arteriovenous malformation Known hemorrhagic diathesis , coagulation deficiency , anticoagulant therapy International Normalized Ratio ( INR ) &gt; 1.7 Baseline platelet &lt; 50,000 Use IV heparin past 48 hour PTT &gt; 1.5 time normalized ratio Baseline glucose &lt; 50mg/dL &gt; 300mg/dL Life expectancy le 90 day prior stroke onset Participation another clinical investigation could confound evaluation study device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>large vessel occlusion</keyword>
	<keyword>mechanical thrombectomy</keyword>
	<keyword>revascularization</keyword>
	<keyword>Penumbra System</keyword>
	<keyword>Separator 3D</keyword>
</DOC>